Healthcare Sector Outlook 2026 | EY Growth Strategy Guide

The Healthcare Sector Outlook 2026: Growth Amid Mounting Headwinds

The healthcare sector outlook for 2026 presents a complex picture of elevated utilization, persistent cost pressures, and transformative strategic opportunities. According to EY-Parthenon’s comprehensive analysis, healthcare utilization remained elevated throughout 2025, driving growth even as organizations navigated a challenging operating environment. Industry forces continue to reshape strategic priorities, including volume migration to lower-cost care settings, advances in value-based care maturity, breakthroughs in artificial intelligence and therapeutics, and rising consumer expectations for transparency and value.

Healthcare executives face six primary headwinds expected to create increased complexity in the coming year: government program enrollment and funding declines, elevated cost of capital, wage and supply cost inflation, persistent workforce shortages, consumer transparency and value expectations, and sustained federal and state regulatory scrutiny. These pressures collectively force leaders to rethink their position in the healthcare value chain, fundamentally altering how organizations approach growth, efficiency, and patient care delivery. As explored in our analysis of capital markets trends across industries, the elevated cost of capital is a theme affecting multiple sectors simultaneously.

The changing landscape is shifting economic returns and cash flows for operating healthcare assets, compelling leaders to pursue four strategic growth opportunities: profitable expansion in lower-acuity care, innovative cost containment strategies, strategic AI investments, and opportunistic mergers and acquisitions. Organizations that execute effectively across these dimensions will be best positioned to deliver value in an increasingly competitive environment.

How the One Big Beautiful Bill Act Reshapes Healthcare Economics

The One Big Beautiful Bill Act (OBBBA), passed in 2025, introduces significant economic impacts across virtually every segment of the healthcare sector. According to EY-Parthenon’s analysis, the legislation affects health systems, hospitals, providers, government plans including Medicare and Medicaid, pharmacies and pharmacy benefit managers, private equity investors, and ACA and commercial coverage providers. The interconnectedness and complexity introduced by the OBBBA represents one of the most consequential regulatory developments for healthcare organizations entering 2026.

The OBBBA creates increased regulatory and financial pressures that cascade across provider and payer organizations. For health systems and hospitals, the legislation compounds existing reimbursement challenges with new compliance requirements. Government plan administrators face enrollment fluctuations as program funding shifts, while pharmacies and PBMs navigate expanded oversight provisions. Private equity investors must reassess their healthcare portfolio strategies in light of changing regulatory dynamics.

These legislative changes make the healthcare sector outlook for 2026 particularly nuanced. Organizations that proactively adapt their strategic planning to account for OBBBA provisions will gain competitive advantages, while those that delay may find themselves caught between tightening margins and increasing operational requirements. Understanding the full scope of these impacts is essential for effective resource allocation and investment decisions across the healthcare ecosystem. The Centers for Medicare & Medicaid Services provides updated guidance on program changes affecting reimbursement structures.

Profitable Expansion in Lower-Acuity Care Settings

Ambulatory and post-acute services represent the primary engine for healthcare sector volume growth in 2026, fueled by cost pressures, an aging population, therapeutic advances, and the maturation of value-based care models. Industry forecasts indicate that outpatient and post-acute care will outpace population growth over the next decade, with services including behavioral health, post-acute care, physician practices, and ambulatory surgery centers all positioned for significant patient volume expansion through 2035.

However, lower-acuity care presents meaningful economic challenges for certain healthcare organizations, particularly those operating under fee-for-service arrangements. ASC procedural rates can be 40% to 60% lower than hospital outpatient department rates based on CMS benchmarks, with far less variability in pricing. This constrained price flexibility means that profitability in ambulatory settings requires a fit-for-purpose, efficient operating model that organizations must deliberately design and implement.

EY-Parthenon identifies five key strategies for sustainable ambulatory growth. Strategic acquisitions remain viable given lower capital commitments and regulatory scrutiny, with non-traditional players including payers and life sciences companies creating patient network flywheels through physician practice management deals. Service line programming enables differentiated results, with musculoskeletal and cardiovascular procedures increasingly migrating from hospitals to ASCs. Progressive organizations are reprogramming their ASC portfolios to focus on synergistic specialties that maximize margins while maintaining clinical quality standards.

Insourcing and performance improvement represent another critical lever, as mature provider organizations build enhanced ambulatory and post-acute capabilities in-house rather than relying on outside operators. This includes expanding advanced practitioner roles, managing implant and supply expenses strategically, and re-evaluating staffing models. Value-based care investment, particularly in primary care, offers significant upside given that the US continues to lag peer countries in primary care access and utilization according to the Commonwealth Fund.

Healthcare Cost Containment Strategies for Employers in 2026

Healthcare benefit costs have risen at a 5% compound annual growth rate since 2019, creating urgent demand for innovative cost containment approaches. Employer contributions now average approximately $20,000 per family in 2025, representing a 33% increase over six years. By contrast, employee contributions have risen only $1,000 to approximately $7,000 on average over the same period, with employers absorbing a disproportionate share of cost increases at a 6% CAGR versus 2% for employees.

The healthcare sector outlook identifies several innovative cost containment opportunities for employers in 2026. Alternative funding models, including level-funded options that blend fully insured and self-funded approaches, present opportunities to improve cost predictability. When coupled with stop-loss protection and surplus refunds, these arrangements help employers manage healthcare expenses more directly while maintaining appropriate risk mitigation.

Individual Coverage Health Reimbursement Arrangements (ICHRAs) represent one of the fastest-growing cost management tools, with adoption rates increasing approximately 20% from 2024 to 2025. Small employers have shown particularly high adoption rates, driven by unstable costs in fully funded plans and workforce preferences for customized benefits. However, barriers remain including employee abrasion risks, broker acceptance challenges, and regulatory volatility.

Technology-driven platforms and services that deliver clear, data-backed return on investment represent a strategic opportunity for proactive benefit cost management. Scalable solutions focused on specific cost drivers, such as disease state management and out-of-network claims containment, are demonstrating quantifiable results. Similar to how AI is transforming productivity across industries, healthcare employers can leverage AI-powered analytics to identify cost reduction opportunities and optimize their benefit strategies.

Strategic AI Investments Driving Healthcare Transformation

Artificial intelligence represents one of the most significant transformation levers in the healthcare sector outlook for 2026. US healthcare sector organizations are outpacing the broader economy in adoption rates of AI applications, with the acceleration trend persisting since September 2023. The healthcare sector’s AI uptake has grown at approximately three times the rate of the wider economy, reflecting both the significant operational efficiency gains available and the competitive pressures driving adoption.

For payers, AI presents substantial opportunities to improve financial performance and free cash flow across several key applications. Administrative process automation through generative AI can handle routine tasks including claims processing, billing, and coding, converting raw data into actionable information while reducing manual intervention. This automation accelerates workflows, reduces administrative overhead, and lowers error and denial rates, leading to more efficient revenue cycle management and improved resource allocation.

Personalization in benefits design and member engagement represents another high-value AI application. By analyzing large volumes of member data, AI identifies individual needs and preferences, enabling insurers to tailor benefits packages, send targeted wellness reminders, and provide proactive outreach through virtual assistants and personalized communication channels. These capabilities improve member satisfaction and health outcomes simultaneously, creating a virtuous cycle of engagement and value creation that enhances competitive positioning.

For providers, healthcare AI investments in 2026 should focus on clinical decision support, operational workflow optimization, and predictive analytics for patient outcomes. The US Department of Health and Human Services continues to update its AI governance frameworks, providing guidance for responsible deployment in clinical settings.

Healthcare AI Adoption Rates Outpacing the Broader Economy

Data from Menlo Ventures’ State of AI in Healthcare report reveals that healthcare sector AI adoption has reached a critical inflection point. Health systems lead with a 27% adoption rate for paid commercial AI licenses, significantly ahead of the overall US economy baseline. Outpatient organizations follow closely, while payers show the lowest adoption rate at 14%, suggesting significant untapped opportunity for insurance organizations willing to invest in AI capabilities.

The three-times growth differential between healthcare and the broader economy reflects several sector-specific dynamics. Healthcare generates enormous volumes of structured and unstructured data that AI can process more efficiently than traditional methods. The administrative complexity of healthcare operations, from prior authorization to claims adjudication, creates natural automation targets where AI can deliver immediate, measurable returns. Additionally, workforce shortages amplify the urgency of technology investments that can augment human capabilities and extend organizational capacity.

Looking forward, the healthcare sector outlook suggests that AI adoption will continue accelerating through 2026 and beyond, with generative AI applications expanding from administrative automation into clinical workflows, drug discovery, and population health management. Organizations that establish robust AI governance frameworks and data infrastructure now will compound their advantages as more sophisticated applications become available. The competitive gap between AI-forward and AI-lagging healthcare organizations is expected to widen significantly in the coming years, making strategic AI investment a strategic imperative rather than an optional enhancement.

Opportunistic Mergers and Acquisitions for Health Systems

While regional health system mergers and acquisitions scaled back in 2025 due to elevated capital costs and regulatory headwinds, the healthcare sector outlook identifies targeted M&A as a critical growth lever for 2026. Academic medical centers have sustained transaction activity despite the broader slowdown, driven by mounting pressures from reimbursement challenges, labor shortages, cost inflation, and the imperative to invest in leading clinical programs, recruit outstanding provider faculty, and sustain research and educational missions.

The strategic rationale for healthcare M&A in 2026 centers on capacity management and network optimization. Many of the top 20 US academic medical centers by staffed bed size have exceeded the 80-85% bed utilization threshold commonly used for strategic planning. While inpatient volume growth has been modest, higher patient acuity has resulted in sustained utilization levels, underscoring ongoing capacity challenges and the need for strategic management of inpatient resources through network expansion.

Expanding acute care networks through acquisitions has proven effective in alleviating AMC inpatient capacity constraints. M&A unlocks patient volume growth, enables strategic bed management, and preserves complex care at flagship hospitals while distributing appropriate cases across the expanded network. For organizations considering transaction strategies, our analysis of cross-industry consolidation trends provides additional strategic context.

Academic Medical Centers: Sustaining Growth Through Strategic M&A

Academic medical centers occupy a unique position in the healthcare sector outlook for 2026. Their structural, financial, and strategic differences from community health systems enable continued M&A activity even in the current constrained capital and regulatory environment. The largest US AMCs have maintained high bed utilization, with many operating well above the strategic planning threshold, creating both capacity pressures and strategic acquisition rationale.

Targeted hospital network acquisitions enable AMCs to expand their brand presence to acquired community hospitals, amplifying patient volumes while fueling utilization of higher-end tertiary and quaternary services. The “hub and spoke” operating model represents a transformative approach where flagship AMCs serve as specialized care hubs while community hospitals deliver cost-effective inpatient care for lower-acuity cases. This model creates seamless patient transfer pathways, prevents patient leakage, and optimizes resource allocation across the entire network.

Successful execution of hub-and-spoke strategies requires careful integration planning, clinical governance alignment, and technology infrastructure investment. AMCs must balance their academic missions of research, education, and complex care with the operational efficiencies needed to sustain expanded community hospital networks. Those that achieve this balance will create durable competitive advantages that strengthen their market position and improve community health outcomes simultaneously. The Association of American Medical Colleges tracks AMC performance metrics that inform strategic M&A planning.

Building Resilient Healthcare Operating Models for the Future

The healthcare sector outlook for 2026 demands that organizations build resilient operating models capable of thriving amid persistent headwinds. Strategic adaptation is crucial for optimizing economic returns and free cash flow in an environment where multiple pressures converge simultaneously. The ongoing migration to lower-cost care settings, investments in AI-driven solutions, proactive benefit cost management, and targeted M&A activity represent interconnected strategic levers that leaders must orchestrate cohesively rather than pursue in isolation.

Organizations that succeed in 2026 will demonstrate several common characteristics: agile strategic planning processes that respond rapidly to regulatory and market changes, data-driven decision-making powered by advanced analytics and AI capabilities, disciplined capital allocation that balances growth investments with margin protection, and workforce strategies that address persistent shortages through technology augmentation, flexible staffing models, and competitive compensation structures.

Partnerships and joint ventures continue to present growth opportunities at a time when capital remains costly. Operating partnerships in urgent care, ambulatory surgery, freestanding imaging, home health, micro-hospitals, rehabilitation, and behavioral health offer paths to expansion with reduced capital requirements. While several post-acute joint ventures dissolved in 2025, the underlying strategic logic for partnership-based growth remains sound when executed with appropriate governance structures and aligned incentive models.

The healthcare leaders who embrace these interconnected trends and implement sustainable, technology-enabled operating models will be best positioned to unlock value, build resilience, and deliver superior patient outcomes in the evolving healthcare landscape. The Kaiser Family Foundation provides ongoing data tracking on healthcare market dynamics that supports evidence-based strategic planning.